MyPeBS
is an international
EU-funded clinical study
that evaluates a new breast cancer screening strategy

MyPeBS (My Personal Breast Screening) is a major and ambitious project funded by the European Union. The aim of this unique international clinical trial is to compare a personalised risk-based screening strategy (based on each woman’s individual risk of developing breast cancer in the coming years) with the current standard screening in volunteer women aged between 40 and 70 recruited in 6 countries: Belgium, Spain, France, Israel, Italy and the UK.
The study enrolled 53,143 female participants between June 2019 and July 2023.
The results are expected by the end of 2027

MyPeBS (My Personal Breast Screening) is a major ambitious European initiative. This unique international clinical study compares a personalised risk-based screening strategy (based on the individual women’s risk of developing breast cancer) to standard screening among 85,000 women aged 40 to 70 in 6 countries: Belgium, France, Israel, Italy, United Kingdom and Spain.